NMN/NaMN Adenylyltransferase (NMNAT) and NAD Kinase (NADK) Inhibitors: Chemistry and Potential Therapeutic Applications

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|13|1973-1992

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.13, 2011-05, pp. : 1973-1992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Therapeutic potential of phosphoinositide 3-kinase inhibitors

By Drees Beth E   Mills Gordon B   Rommel Christian   Prestwich Glenn D  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 703-732

Informa Healthcare

Access to resources Recommend Favorite

Modulation of Cytotoxicity of Benzamide Riboside by Expression of NMN Adenylyltransferase

By  

Current Medicinal Chemistry, Vol. 9, Iss. 7, 2002-04 ,pp. : 749-758

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure

By Karmazyn M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 835-843

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1767-1784

Bentham Science Publishers

Access to resources Recommend Favorite